Intco Medical Technology (300677.SZ) plans to spend 80-120 million yuan to repurchase shares.
Yingke Medical (300677.SZ) announcement, the company plans to use its own funds to repurchase a portion through centralized bidding...
Intco Medical Technology (300677.SZ) announced that the company plans to use its own funds to repurchase some of its company shares through centralized bidding trading (RMB ordinary shares (A shares)) for the implementation of an employee stock ownership plan and/or equity incentive. The total amount of repurchase funds will not be less than RMB 80 million (inclusive) and not more than RMB 120 million (inclusive), with a repurchase price limit of RMB 26.66 per share (inclusive).
Related Articles

HK Bull/Bear Outstanding Qty Ratio(60:40) | March 14th

The seven giants of the US stock market have all entered a technical correction zone. Microsoft Corporation (MSFT.US) has fallen by more than 18% since the beginning of this year.

Overnight US stocks | The S&P 500 Index hit a new low for the year, with Brent oil closing above $100 for the second consecutive day. Adobe (ADBE.US) fell 7.5%.
HK Bull/Bear Outstanding Qty Ratio(60:40) | March 14th

The seven giants of the US stock market have all entered a technical correction zone. Microsoft Corporation (MSFT.US) has fallen by more than 18% since the beginning of this year.

Overnight US stocks | The S&P 500 Index hit a new low for the year, with Brent oil closing above $100 for the second consecutive day. Adobe (ADBE.US) fell 7.5%.

RECOMMEND

“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
11/03/2026

Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
11/03/2026

U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
11/03/2026


